The results from the in vivo studies were consistent with those of the in vitro experiments, demonstrating that both inhibition of PD-L1 and knockdown of IGF2BP2 could significantly reduce the growth of hypopharyngeal tumors. This evidence concerns the gene CD274 and neoplasm of hypopharynx.